|
|
Volumn 5, Issue 2, 2015, Pages 100-101
|
|
Pembrolizumab shows potential in breast cancer
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
PEMBROLIZUMAB;
FEMALE;
HUMAN;
PHASE 1 CLINICAL TRIAL (TOPIC);
TRIPLE NEGATIVE BREAST NEOPLASMS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS, PHASE I AS TOPIC;
FEMALE;
HUMANS;
TRIPLE NEGATIVE BREAST NEOPLASMS;
|
|
EID: 84941625200
PISSN: None
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.CD-NB2014-184 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|